Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
- USD | -.--% | -0,07% | +269,92% |
2019 | Transcript : Dova Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 06, 2019 | |
2019 | Transcript : Dova Pharmaceuticals, Inc. - Special Call |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mahmood Ladha
PSD | President | 60 | 12/11/19 |
Lee F. Allen
CTO | Chief Tech/Sci/R&D Officer | 72 | 01/04/17 |
Marc Banjak
LAW | General Counsel | - | - |
Bill L. Nichols
SAM | Sales & Marketing | - | 15/02/18 |
Stephen Crane
SAM | Sales & Marketing | - | - |
Caroline Diaz
LAW | General Counsel | - | - |
Corporate Secretary | 49 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Henrik Stenqvist
BRD | Director/Board Member | 57 | 12/11/19 |
Guido Oelkers
BRD | Director/Board Member | 59 | 12/11/19 |
Director/Board Member | 55 | 12/11/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 28 821 405 | 13 851 527 ( 48,06 %) | 0 | 48,06 % |
Coordinate società
Dova Pharmaceuticals, Inc.
240 Leigh Farm Road Suite 245
27707, Durham
+919-748-5975
http://www.dova.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+269,92% | 808 Mln | |
+15,58% | 122 Mrd | |
+16,60% | 113 Mrd | |
+17,55% | 26,22 Mrd | |
-24,33% | 19,01 Mrd | |
-19,14% | 15,71 Mrd | |
-17,95% | 15,22 Mrd | |
-46,81% | 14,72 Mrd | |
+58,78% | 14,58 Mrd | |
+4,91% | 13,84 Mrd |
- Borsa valori
- Azioni
- Azione DOVA
- Società Dova Pharmaceuticals, Inc.